MENU
+Compare
PROCF
Stock ticker: OTC
AS OF
Dec 31 closing price
Price
$0.03
Change
-$0.02 (-40.00%)
Capitalization
57.83M

PROCF Procaps Group, S.A. Forecast, Technical & Fundamental Analysis

Procaps Group SA is an integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions, medicines, and hospital supplies... Show more

PROCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PROCF with price predictions
Jan 14, 2026

PROCF's RSI Oscillator ascends from oversold territory

The RSI Oscillator for PROCF moved out of oversold territory on December 29, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PROCF as a result. In of 128 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for PROCF entered a downward trend on December 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PROCF's P/B Ratio (277.778) is slightly higher than the industry average of (29.698). P/E Ratio (0.063) is within average values for comparable stocks, (76.061). PROCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.042). PROCF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.006) is also within normal values, averaging (72.584).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PROCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PROCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
PROCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKHHY36.190.67
+1.88%
Heineken Holding N.V.
CYYNF0.15N/A
N/A
Cynata Therapeutics Ltd.
GTMEF41.95N/A
N/A
Globe Telecom, Inc.
SRKZF0.04N/A
N/A
Sky Gold Corp.
CCGFF10.12N/A
N/A
Credit Corp Group Ltd.

Groups containing PROCF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROCF
1D Price
Change %
PROCF100%
N/A
Pharmaceuticals: Generic
industry (218 stocks)
3%
Poorly correlated
-0.29%
Pharmaceuticals
industry (383 stocks)
-2%
Poorly correlated
-0.13%